Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001439222-21-000042
Filing Date
2021-05-24
Accepted
2021-05-24 16:44:00
Documents
1
Period of Report
2021-05-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162188902273056.html 4  
1 FORM 4 wf-form4_162188902273056.xml 4 6312
  Complete submission text file 0001439222-21-000042.txt   7760
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Issuer) CIK: 0001439222 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AGIOS PHARMACEUTICALS, INC. 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Ho Maykin (Reporting) CIK: 0001646395 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36014 | Film No.: 21955605